Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
The CARE1 pragmatic clinical trial was designed to determine the optimal treatment combination for patients with metastatic kidney cancer, using a specific biomarker. The trial, funded by the…
Ken Berry, MD, a family physician, discusses polycystic kidney disease (PKD), the most common inherited kidney disease. PKD is characterized by enlarging cysts in the kidney that can…
Polycystic kidney disease (PKD) is a common cause of secondary hypertension, particularly in young people. PKD is a group of disorders, with the most relevant being autosomal dominant…
Mohamed Tinawi, MD, a nephrologist from Northwest Indiana, provides an update from Kidney Week 2023, discussing several significant studies and trials. Results from the DUPLEX trial, published in…
Michael Collins, MBChB, FRACP, PhD, a kidney transplant specialist at the Royal Adelaide Hospital, discusses his research on improving kidney transplant outcomes. He explains that during organ donation,…
Edward P.K. Kwakyi, BSc, and Rasheed A. Gbadegesin, MBBS, MD, FASN, discuss the role of apolipoprotein L1 (APOL1) in kidney diseases, particularly in people of African ancestry. APOL1…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, discusses the treatment of large kidney tumors. Historically, most kidney cancers presented as large masses, but with advancements in…
Brad Leibovich, MD, a urologic oncologist at Mayo Clinic, explains that kidney cancer in its early stages often presents no signs or symptoms and there is no screening…
Rajiv Agarwal, MD, BS, a renowned nephrology expert, discusses the importance of early detection and treatment of chronic kidney disease (CKD), particularly in patients with type 2 diabetes.…
Surya Seshan, MBBS, of New York-Presbyterian Hospital and Weill Cornell Medical College, discusses the basics of antiphospholipid antibody syndrome, first described by Professor Hughes in the 1980s. The…
